Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis

Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis

Abstract Background Some studies have investigated the prognostic value exhibited by the Prognostic Nutritional Index (PNI) in patients suffering diffuse large B-cell lymphoma (DLBCL), but varying results were obtained. In order to determine the specific prognostic value more accurately, a meta-anal...

Full description

Bibliographic Details
Main Authors:	Chunyan Luan, Fei Wang, Ning Wei, Baoan Chen
Format:	Article
Language:	English
Published:	BMC 2020-09-01
Series:	Cancer Cell International
Subjects:	Meta-analysis Prognostic nutritional index Diffuse large B-cell lymphoma Prognosis
Online Access:	http://link.springer.com/article/10.1186/s12935-020-01535-x

Similar Items

Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis
by: Ying Chen, et al.
Published: (2019-09-01)

Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose–response meta-analysis
by: Shidai Mu, et al.
Published: (2018-08-01)

Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma
by: SV Samarina, et al.
Published: (2019-09-01)

Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports
by: Sun HL, et al.
Published: (2016-05-01)

Identification of an individualized RNA binding protein‐based prognostic signature for diffuse large B‐cell lymphoma
by: Yongzhi Xie, et al.
Published: (2021-04-01)

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients
by: Marcia Torresan Delamain, et al.

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
by: Kim Yu, et al.
Published: (2012-08-01)

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
by: Ting-Xun Lu, et al.
Published: (2019-06-01)

Identification of prognostic factors in patients with diffuse large B-cell lymphoma
by: Fang Peng, et al.
Published: (2017-01-01)

CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
by: Sun J, et al.
Published: (2021-04-01)

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
by: Feifei Sun, et al.
Published: (2018-01-01)

Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma
by: Jin Roh, et al.
Published: (2020-03-01)

Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma
by: Lin X, et al.
Published: (2017-10-01)

PROGNOSTIC SIGNIFICANCE OF MEDIASTINAL MASS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA CS II – CASE STUDY
by: Olivera Simonović
Published: (2014-06-01)

Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma
by: Zanzan Wang, et al.
Published: (2021-05-01)

Primary breast diffuse large B-cell lymphoma in the era of rituximab
by: Zhang N, et al.
Published: (2016-10-01)

The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis
by: Liping Qiu, et al.
Published: (2019-03-01)

Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma
by: Yuan Cheng, et al.
Published: (2019-08-01)

Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy
by: Clausen MR, et al.
Published: (2019-11-01)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
by: Xiao‐bo Ma, et al.
Published: (2018-09-01)

Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma
by: Zhang Zizhen, et al.
Published: (2012-06-01)

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
by: Wenting Huang, et al.
Published: (2017-12-01)

Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
by: Frédérique Larousserie, et al.
Published: (2019-06-01)

Prognostic Significance of LDH Ratio in Serum/Cerebral Spinal Fluid of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma
by: Liu YZ, et al.
Published: (2019-12-01)

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index
by: Hanne Due, et al.
Published: (2020-03-01)

Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis
by: Yuan-Rong Ren, et al.
Published: (2015-01-01)

OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B‐cell lymphoma
by: Huan Dong, et al.
Published: (2020-03-01)

Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma
by: Se-Il Go, et al.
Published: (2020-05-01)

Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
by: Janet Ofelia Guevara-Canales, et al.
Published: (2013-11-01)

Prognostic Significance of MiRNA in Patients with Diffuse Large B-Cell Lymphoma: a Meta-Analysis
by: Zhuojun Zheng, et al.
Published: (2016-10-01)

Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017-01-01)

Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models – A Systematic Review
by: Jelicic J, et al.
Published: (2020-05-01)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
by: Stefano A. Pileri, et al.
Published: (2021-03-01)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
by: Boram Lee, et al.
Published: (2021-03-01)

Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes
by: Tao Pan, et al.
Published: (2021-02-01)

Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era
by: Qin Wang, et al.
Published: (2016-01-01)

Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type
by: Ningning Yao, et al.
Published: (2020-06-01)

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma
by: Mengmeng Pan, et al.
Published: (2021-06-01)

Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients
by: YANG Ming, et al.
Published: (2020-08-01)

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count
by: Yan-Li Li, et al.
Published: (2019-11-01)